Ruth Nussenzweig, Malaria Researcher, Dies

The microbiologist’s research led to the development of the first human malaria vaccine.

| 2 min read

Register for free to listen to this article
Listen with Speechify
0:00
2:00
Share

NYU LANGONE HEALTH

Ruth Nussenzweig, a leader in the worldwide fight against malaria, died earlier this month (April 1). She was 89 years old.

Nussenzweig, a professor emerita of microbiology and pathology at New York University’s Langone Medical Center, was chair of the department of medical and molecular parasitology for nearly 20 years—the first woman to hold the position. She was elected to the Health and Medicine Division of the National Academies in 2006 and the National Academy of Sciences in 2013.

“Her work in the field of immunology serves as a guide for the development of a new generation of recombinant vaccines,” Maurício Martins Rodrigues told Agência FAPESP in 2013.

Nussenzweig was born in 1928 to Jewish parents in Vienna. In 1939, her family fled to Brazil ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here

Keywords

Meet the Author

  • Jim Daley

    This person does not yet have a bio.
Share
TS Digest January 2025
January 2025, Issue 1

Why Do Some People Get Drunk Faster Than Others?

Genetics and tolerance shake up how alcohol affects each person, creating a unique cocktail of experiences.

View this Issue
Sex Differences in Neurological Research

Sex Differences in Neurological Research

bit.bio logo
New Frontiers in Vaccine Development

New Frontiers in Vaccine Development

Sino
New Approaches for Decoding Cancer at the Single-Cell Level

New Approaches for Decoding Cancer at the Single-Cell Level

Biotium logo
Learn How 3D Cell Cultures Advance Tissue Regeneration

Organoids as a Tool for Tissue Regeneration Research 

Acro 

Products

Artificial Inc. Logo

Artificial Inc. proof-of-concept data demonstrates platform capabilities with NVIDIA’s BioNeMo

Sapient Logo

Sapient Partners with Alamar Biosciences to Extend Targeted Proteomics Services Using NULISA™ Assays for Cytokines, Chemokines, and Inflammatory Mediators

Bio-Rad Logo

Bio-Rad Extends Range of Vericheck ddPCR Empty-Full Capsid Kits to Optimize AAV Vector Characterization

Scientist holding a blood sample tube labeled Mycoplasma test in front of many other tubes containing patient samples

Accelerating Mycoplasma Testing for Targeted Therapy Development